<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mice lacking the imprinted Cdk inhibitor p57(KIP2) have altered cell proliferation and differentiation, leading to abdominal muscle defects; <z:hpo ids='HP_0000175'>cleft palate</z:hpo>; endochondral bone ossification defects with incomplete differentiation of hypertrophic chondrocytes; renal medullary <z:mpath ids='MPATH_589'>dysplasia</z:mpath>; <z:mp ids='MP_0008299'>adrenal cortical hyperplasia</z:mp> and cytomegaly; and lens cell hyperproliferation and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="1" pm="."><plain>Many of these phenotypes are also seen in patients with <z:e sem="disease" ids="C0004903" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Beckwith-Wiedemann syndrome</z:e>, a pleiotropic <z:e sem="disease" ids="C0019247" disease_type="Disease or Syndrome" abbrv="">hereditary disorder</z:e> characterized by <z:hpo ids='HP_0001548'>overgrowth</z:hpo> and predisposition to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>, suggesting that loss of p57(KIP2) expression may play a role in the condition </plain></SENT>
</text></document>